Skip to main content

INNO · INNOCAN PHARMA Corp · Financials

1.82 CAD -0.08 (-4.21%) At close · Nov 5 Intraday price with Plus
Volume · Nov 5 1301 Avg daily vol (3M) 2517

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
$8000
FY2020

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2020
$8000
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.